Postpartum Rh immunoprophylaxis

Obstetrics and Gynecology

Volumn 120, Issue 6, 2012, Pages 1428-1438

  Sandler, S Gerald ^a   Gottschall, Jerome L ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ARTICLE; BLOOD VOLUME; DOSE CALCULATION; ERYTHROCYTE; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMAN; IMMUNOPROPHYLAXIS; PRIORITY JOURNAL; PUERPERIUM; RHESUS IMMUNIZATION;

ERYTHROCYTES; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN; TREATMENT OUTCOME;

EID: 84870204299     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182742eba     Document Type: Article

References (53)

1. American College of Obstetrics and Gynecology. Prevention of Rh D alloimmunization. ACOG Practice Bulletin 4. Washington, DC: ACOG; 1999.
2. Bowman JM. The prevention of Rh immunization. Transfus Med Rev 1988;2:129-50.
3. Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol 1998;110:281-92. (Pubitemid 28406985)
4. Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J 1978;118:623-7. (Pubitemid 8323603)
5. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003;43:1661-6. (Pubitemid 37518071)
6. Pollock W, Gorman J, Freda VJ, Ascari WQ, Allen AE, Baker WJ. Results of clinical trials of RhoGAM in women. Transfusion 1968;8:151-3.
7. Sandler SG, Sathyamoothy S. Laboratory methods for Rh immunoprophylaxis: A review. Immunohematology 2010;26: 92-103.
8. Transfusion Medicine Resource Committee. Surveys 2012.
9. HBF-A. Fetal RBC detection. Participant summary. Northfield (IL): College of American Pathologists; 2012.
10. Sebring ES, Polesky HF. Fetomaternal hemorrhage: Incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990;30:344-57. (Pubitemid 20180830)
11. Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical manual. 17th ed. Bethesda (MD): AABB; 2011.
12. Shepard MK, Weatherall DJ, Conley CL. Semi-quantitative estimates of the distribution of fetal hemoglobin in red cell populations. Bull Johns Hopkins Hosp 1962;110:293-310.
13. Boyer SH, Belding TK, Margolet L, Noyes AN, Burke PJ, Bell WR. Variations in the frequency of fetal hemoglobinbearing erythrocytes (F-cells) in well adults, pregnant women, and adult leukemics. Johns Hopkins Med J 1975;137:105-15.
14. Rochette J, Craig JE, Thein SL. Fetal hemoglobin levels in adults. Blood Rev 1994;8:213-24. (Pubitemid 124019908)
15. Popat N,Wood WG,Weatherall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977;2:377-9. (Pubitemid 8164398)
16. Nance SJ, Nelson JM, Arndt PA, Lam C, Garratty G. Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method. Am J Clin Pathol 1989;91:288-92. (Pubitemid 19074537)
17. Nelson M, Popp H, Horky K, Forsyth C, Gibson J. Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women. Immunohematology 1994; 10:55-9. (Pubitemid 24183407)
18. Kumpel BM. Quantification of anti-D and fetomaternal hemorrhage by flow cytometry. Transfusion 2000;40:6-9. (Pubitemid 30053538)
19. Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998;38: 749-56. (Pubitemid 28381744)
20. Mundee Y, Bigelow NC, Davis BH, Porter JB. Simplified flow cytometric method for fetal hemoglobin containing red blood cells. Cytometry 2000;42:389-93. (Pubitemid 32047570)
21. Dziegiel MH, Nielsen LK, Berkowicz A. Detecting fetomaternal hemorrhage by flow cytometry. Curr Opin Hematol 2006;13: 490-5. (Pubitemid 44607453)
22. Ramsey G; for the College of American Pathologists Transfusion Medicine Resource Committee. Inaccurate doses of Rh immune globulin after Rh-incompatible fetomaternal hemorrhage: Survey of laboratory practice. Arch Pathol Lab Med 2009;133:465-9.
23. Paxton A. Bringing new rigor to RhIg calculations. CAP Today 2008;22:1.
24. Sandler SG. Effectiveness of the RhIg Dose Calculator. Arch Pathol Lab Med 2010;134:967-8.
25. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter Friedrich, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385-93. (Pubitemid 29019427)
26. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol 2006;13:476-83. (Pubitemid 44607451)
27. Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011;44:81-91.
28. Flegel WA, Dennome GA, Yazer MH. On the complexity of D antigen testing: A handy decision tree in the age of molecular blood group genetics. J Obstet Gynaecol Can 2007;29:746-52.
29. Stratton F. A new Rh allelomorph. Nature 1946;158:25.
30. Agre PC, Davies DM, Issett PD, Lamy BM, Schmidt PJ, Treacy M, Vengelen-Tyler V. A proposal to standardize terminology for weak D antigen. Transfusion 1992;32:86-7.
31. Tippett P, Sanger R. Observations on subdivisions of the Rh antigen D. Vox Sang 1962;7:9-13.
32. Queenan JT. The partial D antigen dilemma. Obstet Gynecol 2012;119:421-2.
33. Argall CI, Ball JM, Trentelman E. Presence of anti-D antibody in the serum of a Du patient. J Lab Clin Med 1953;41:895-8.
34. Brandstadter W, Brandstadter M. [Hemolytic disease of the newborn caused by anti-D with factor Du in the mother] [in German]. Zentralbl Gynakol 1970;6:176-8.
35. Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of the newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23:91-4. (Pubitemid 13119115)
36. Cannon M, Pierce R, Tabor EB, Schucker J. Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet Gynecol 2003;102:1143-5. (Pubitemid 37357077)
37. Shao C-P, Xu H, Xu Q, Sun G-D, Li J-P, Chang B-W, et al. Antenatal prophylaxis is unnecessary for 'Asian type' DEL women. Transfus Clin Biol 2010;17:260-4.
38. Lubenko A, Contreras M, Habash J. Should anti-Rh immunoglobulin be given to D variant women? Br J Haematol 1989:72: 429-33. (Pubitemid 19180055)
39. Lurie S, Rotmensch S, Glezerman M. Prenatal management of women who have partial Rh (D) antigen. BJOG 2001;108: 895-7. (Pubitemid 32778581)
40. Sandler SG, Li W, Langeberg A, Landy HJ. New laboratory procedures and Rh blood type changes in a pregnant woman. Obstet Gynecol 2012;119:426-8.
41. Scott ML. Rh serology: Co-coordinator's report. 4th international workshop monoclonal antibodies against human red cell surface antigens. Trans Clin Biol 2002;9:23-9.
42. Anderson B, Shad AT, Gootenberg JE, Sandler SG. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol 1999;60:245-7. (Pubitemid 29108780)
43. Laspina S, O'riordan JM, Lawlor E, Murphy WG. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin. Vox Sang 2005;89: 49-51. (Pubitemid 40839549)
44. Werch JB. Prevention of Rh sensitization in the context of trauma: Two case reports. J Clin Apher 2010;25:70-3.
45. Werch J, Todd C. Resolution by erythrocytapheresis of the exposure of an Rh-negative person to Rh-positive cells. An alternative treatment. Transfusion 1993;33:530-2. (Pubitemid 23183217)
46. Nester TA, Rumsey DM, Howell CC, Gilligan DM, Drachman JG, Maier RV, et al. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin. Transfusion 2004;44:1720-3. (Pubitemid 39644056)
47. Ewing CA, Rumsey DH, Langeberg AF, Sandler SG. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets. Immunohematology 1998;114:133-137.
48. Samson D, Mollison PL. Effect on primary Rh-immunization of delayed administration of anti-Rh. Immunology 1975;28: 349-57.
49. Kennedy MS, McNanie J, Waheed A. Detection of anti-D following antepartum injections of Rh immune globulin. Immunohematology 1998;14:138-40.
50. Lee D, Contreras M, Robson SC, Rodel CH, Whittle MJ. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfus Med 1999;9:93-7. (Pubitemid 29134082)
51. Klein HJ, Anstee D, editors. Mollison's blood transfusion in clinical medicine. 11th ed. Malden (MA): Blackwell Science Ltd; 2008. p. 521.
52. Ness P, Salamon JL. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. Am J Clin Pathol 1986;85:604-6. (Pubitemid 16061131)
53. Despotovic JM, Lambert MP, Herman JH, Gernsheimer TB, McCrae KR, Tarantino MD. RHIG for the treatment of immune thrombocytopenia: Consensus and controversy (CME). Transfusion 2012;52:1126-36; quiz 1125.